Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 5Multiple Myeloma 4Barrett Esophagus 3Venous Thromboembolism 2Tobacco Use Disorder 2Prostatic Neoplasms 2Precancerous Conditions 2Polycythemia Vera 2Myocardial Infarction 2Esophageal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Vascular Diseases 1Triple Negative Breast Neoplasms 1Thromboembolism 1Thrombocytopenia 1Thrombocythemia, Essential 1Stroke 1Soft Tissue Neoplasms 1Smoking Cessation 1Sarcoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Node Positive HER2 Negative Breast Cancer 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Neoplasm Metastasis 1Myocardial Ischemia 1Myeloproliferative Disorders 1Multiple Pulmonary Nodules 1

Interventions

Selenium 2alpha-Tocopherol 1Vitamin E 1Rosuvastatin Calcium 1Metformin 1Erlotinib Hydrochloride 1Eflornithine 1Cholecalciferol 1Calcium Carbonate 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Adenomatous Polyps × Aspirin × Clear all
NCT00983580 2019-09-04

Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Completed
107 enrolled 10 charts

Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡